ARCHIVES

Post Reporter Responds To Criticism Of Cancer Series

This article is from The Cancer Letter archive.

Vol. 08 No. 01 | January 1, 1982

Download PDF Visit The Full Archive

Related Articles

EntreMed Begins Phase I/II Trial For Endostatin.

July 27, 2001

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

September 11, 1998

ODAC Clarifies Standards for Maintenance In Ovarian Cancer; Nixes Olaparib in 11-2 Vote

June 27, 2014

Literature Review Supports Need for More Research In Cancer Control

July 19, 1985

Hydridoma Cell Lines Available

March 5, 1982

Rosenberg’s Adoptive Immunotherapy Update

December 6, 1985